DOI QR코드

DOI QR Code

A Novel Heterozygous Mutation (F252Y) in Exon 7 of the IRF6 Gene is Associated with Oral Squamous Cell Carcinomas

  • Melath, Anil (Department of Periodontology, Mahe Institute of Dental Sciences, Union Territory of Pondichery) ;
  • Santhakumar, Gopi Krishnan (Department of Orthodontics, Mahe Institute of Dental Sciences, Union Territory of Pondichery) ;
  • Madhavannair, Shyam Sunder (Department of Oral and Maxillofacial Surgery, Mahe Institute of Dental Sciences, Union Territory of Pondichery) ;
  • Nedumgottil, Binoy Mathews (Department of Prosthodontics, Mahe Institute of Dental Sciences, Union Territory of Pondichery) ;
  • Ramanathan, Arvind (Human Genetics Laboratory, Sree Balaji Medical and Dental College and Hospital, Bharath University)
  • Published : 2013.11.30

Abstract

Background: Interferon regulatory factor 6 (IRF6) is a transcription factor with distinct and conserved DNA and protein binding domains. Mutations within the protein binding domain have been significantly observed in subjects with orofacial cleft relative to healthy controls. In addition, recent studies have identified loss of expression of IRF6 due to promoter hypermethylation in cutaneous squamous cell carcinomas. Since mutational events occurring within the conserved domains are likely to affect the function of a protein, we investigated whether regions within the IRF6 gene that encodes for the conserved protein binding domain carried mutations in oral squamous cell carcinoma (OSCC). Materials and Methods: Total chromosomal DNA extracted from 32 post surgical OSCC tissue samples were amplified using intronic primers flanking the exon 7 of IRF6 gene, which encodes for the major region of protein binding domain. The PCR amplicons from all the samples were subsequently resolved in a 1.2% agarose gel, purified and subjected to direct sequencing to screen for mutations. Results: Sequencing analysis resulted in the identification of a mutation within exon 7 of IRF6 that occurred in heterozygous condition in 9% (3/32) of OSCC samples. The wild type codon TTC at position 252 coding for phenylalanine was found to be mutated to TAC that coded for tyrosine (F252Y). Conclusions: The present study identified for the first time a novel mutation within the conserved protein binding domain of IRF6 gene in tissue samples of subjects with OSCC.

Keywords

IRF6;IRF6 mutation;IRF6 mutation in oral cancer;IRF6 mutation in Indian cancer

References

  1. Botti E, Spallone G, Moretti F, et al (2011). Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas. Proc Natl Acad Sci USA, 108, 13710-5. https://doi.org/10.1073/pnas.1110931108
  2. Coelho KR (2012). Challenges of the oral cancer burden in India. J Cancer Epidemiol, 2012, 701932.
  3. Gao J, Tian Y, Zhang J (2012). Overexpression of interferon regulatory factor 1 enhances chemosensitivity to 5-fluorouracil in gastric cancer cells. J Cancer Res Ther, 8, 57-61. https://doi.org/10.4103/0973-1482.95175
  4. Jayaraman B, Valiathan GM, Jayakumar K, et al (2012). Lack of mutation in p53 and H-ras genes in phenytoin induced gingival overgrowth suggests its non cancerous nature. Asian Pac J Cancer Prev, 13, 5535-8. https://doi.org/10.7314/APJCP.2012.13.11.5535
  5. Kim TK, Kim T, Kim TY, Lee WG, Yim J (2000). Chemotherapeutic DNA-damaging drugs activate interferon regulatory factor-7 by the mitogen-activated protein kinase kinase-4-cJun NH2-terminal kinase pathway. Cancer Res, 60, 1153-6.
  6. Laljee RP, Muddaiah S, Salagundi B, et al (2013). Interferon stimulated gene - ISG15 is a potential diagnostic biomarker in oral squamous cell carcinomas. Asian Pac J Cancer Prev, 14, 1147-50. https://doi.org/10.7314/APJCP.2013.14.2.1147
  7. Lee KY, Geng H, Ng KM, et al (2008). Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas. Oncogene, 27, 5267-76. https://doi.org/10.1038/onc.2008.147
  8. Li Q, Tainsky MA (2011). Epigenetic silencing of IRF7 and/or IRF5 in lung cancer cells leads to increased sensitivity to oncolytic viruses. PLoS One, 6, 28683. https://doi.org/10.1371/journal.pone.0028683
  9. Mangold E, Ludwig KU, Nothen MM (2011). Breakthroughs in the genetics of orofacial clefting. Trends Mol Med, 17, 725-33. https://doi.org/10.1016/j.molmed.2011.07.007
  10. McGough JM, Yang D, Huang S, et al (2008). DNA methylation represses IFN-gamma-induced and signal transducer and activator of transcription 1-mediated IFN regulatory factor 8 activation in colon carcinoma cells. Mol Cancer Res, 6, 1841-51.
  11. Murugan AK, Munirajan AK, Tsuchida N (2012). Ras oncogenes in oral cancer: the past 20 years. Oral Oncol, 48, 383-92. https://doi.org/10.1016/j.oraloncology.2011.12.006
  12. Ozato K, Tailor P, Kubota T (2007). The interferon regulatory factor family in host defense: mechanism of action. J Biol Chem, 282, 20065-9. https://doi.org/10.1074/jbc.R700003200
  13. Park IS, Walsh CT (1997). D-Alanyl-D-lactate and D-alanyl-D-alanine synthesis by D-alanyl-D-alanine ligase from vancomycin-resistant Leuconostoc mesenteroides. Effects of a phenylalanine 261 to tyrosine mutation. J Biol Chem, 272, 9210-4. https://doi.org/10.1074/jbc.272.14.9210
  14. Pitha-Rowe IF, Pitha PM (2007). Viral defense, carcinogenesis and ISG15: novel roles for an old ISG. Cytokine Growth Factor Rev, 18, 409-17. https://doi.org/10.1016/j.cytogfr.2007.06.017
  15. Rajendran S, Muthupalani RS, Ramanathan A (2013). Lack of RING finger domain (RFD) mutations of the c-Cbl gene in oral squamous cell carcinomas. Asian Pac J Cancer Prev, 14, 1073-5. https://doi.org/10.7314/APJCP.2013.14.2.1073
  16. Salahshourifar I, Sulaiman WA, Zilfalil BA, Halim AS (2011). Contribution of variants in and near the IRF6 gene to the risk of nonsyndromic cleft lip with or without cleft palate in a Malay population. Am J Med Genet A, 155, 2302-7. https://doi.org/10.1002/ajmg.a.34169
  17. Savitsky D, Tamura T, Yanai H, Taniguchi T (2010). Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol Immunother, 59, 489-510. https://doi.org/10.1007/s00262-009-0804-6
  18. Sigismund S, Confalonieri S, Ciliberto A, et al (2012). Endocytosis and signaling: cell logistics shape the eukaryotic cell plan. Physiol Rev, 92, 273-366. https://doi.org/10.1152/physrev.00005.2011
  19. Stuppia L, Capogreco M, Marzo G, et al (2011). Genetics of syndromic and nonsyndromic cleft lip and palate. J Craniofac Surg, 22, 1722-6. https://doi.org/10.1097/SCS.0b013e31822e5e4d
  20. Tamura T, Yanai H, Savitsky D, Taniguchi T (2008). The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol, 26, 535-84. https://doi.org/10.1146/annurev.immunol.26.021607.090400
  21. Valiathan GM, Thenumgal SJ, Jayaraman B, et al (2012). Common docking domain mutation E322K of the ERK2 gene is infrequent in oral squamous cell carcinomas. Asian Pac J Cancer Prev, 13, 6155-7. https://doi.org/10.7314/APJCP.2012.13.12.6155
  22. Warburton G, Nikitakis NG, Roberson P, et al (2007). Histopathological and lymphangiogenic parameters in relation to lymph node metastasis in early stage oral squamous cell carcinoma. J Oral Maxillofac Surg, 65, 475-84. https://doi.org/10.1016/j.joms.2005.12.074
  23. Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM (2005). Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci USA, 102, 10200-5. https://doi.org/10.1073/pnas.0504754102
  24. Zucchero TM, Cooper ME, Maher BS, et al (2004). Interferon regulatory factor 6 (IRF6) gene variants and the risk of isolated cleft lip or palate. N Engl J Med, 351, 769-80. https://doi.org/10.1056/NEJMoa032909